Literature DB >> 11035909

Lower peak bone mass and its decline.

M F Sowers1.   

Abstract

There is evidence that two-thirds of the risk of osteoporotic fracture can be predicted from the pre-menopausal bone mineral density. The frequency of osteoporosis in older women may be modifiable by implementing invention strategies in the pre- and peri-menopausal periods. Lower peak bone mineral density and bone loss can be identified in women with altered reproductive hormone or calciotrophic hormone concentrations, or selected lifestyle practices. Alterations in reproductive hormones may occur in adolescence (from an early age of pregnancy or the amenorrhoea of anorexia nervosa or exercise), in the pre-menopause (nulliparity, oophorectomy, early ovarian failure or marginal hormonal status) or in the peri-menopause. Alterations in calciotrophic hormone concentrations include corticosteroid therapy and breast cancer treatment. Lifestyle risk factors include the misuse of alcohol and possibly smoking, physical inactivity or an imbalance in dietary intake. Effective intervention currently consists of treating underlying conditions and monitoring high-risk groups. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035909     DOI: 10.1053/beem.2000.0076

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Endocrinol Metab


  3 in total

1.  Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women.

Authors:  Kathleen E Bainbridge; MaryFran Sowers; Xihong Lin; Sioban D Harlow
Journal:  Osteoporos Int       Date:  2004-01-22       Impact factor: 4.507

2.  Higher prevalence of osteoporosis among female Holocaust survivors.

Authors:  E-L Marcus; J Menczel
Journal:  Osteoporos Int       Date:  2007-05-11       Impact factor: 4.507

3.  Lean body mass, not estrogen or progesterone, predicts peak bone mineral density in premenopausal women.

Authors:  Lee-Jane W Lu; Fatima Nayeem; Karl E Anderson; James J Grady; Manubai Nagamani
Journal:  J Nutr       Date:  2008-12-23       Impact factor: 4.798

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.